Structure of nogalamycin bound to a DNA hexamer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 87, Issue 6, 1990, Pages 2225-2229

  Williams, Loren Dean ^a   Egli, Martin ^a   Gao, Qi ^a   Bash, Paul ^b   Van Der Marel, Gijs A ^c   Van Boom, Jacques H ^c   Rich, Alexander ^a   Frederick, Christine A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD UNIVERSITY   (United States)

^c LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Anthracycline; Intercalator; Phosphorothioate; X ray crystallography

Indexed keywords

DNA; NOGALAMYCIN;

ARTICLE; GENETIC ENGINEERING; PRIORITY JOURNAL;

BASE SEQUENCE; DAUNORUBICIN; DNA; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NOGALAMYCIN; NUCLEIC ACID CONFORMATION; OLIGODEOXYRIBONUCLEOTIDES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025259309     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.87.6.2225     Document Type: Article

References (30)

1. Acramone, F. & Penco, S. (1988) in Anthracycline and Anathracenedione Based Anticancer Agents, ed. Lown, J. W. (Elsevier, New York), pp. 1-53.
2. Brown, J. R. (1983) in Molecular Aspects of Anti-Cancer Drug Action, eds. Neidle, S. & Waring, M. J. (Macmillan, London), 2nd Ed., pp. 57-92.
3. Bhuyan, B. K. (1967) in Antibiotics, eds. Gottlieb, D. & Shaw, P. D. (Springer, New York), Vol. 1, pp. 173-180.
4. Bhuyan, B. K. & Reusser, F. (1970) Cancer Res. 30, 984-989.
5. Li, L. H., Kuentzel, S. L., Murch, L. L., Pschigoda, L. M. & Krueger, W. C. (1979) Cancer Res. 39, 4816-4822.
6. Fok, J. & Waring, M. J, (1972) Mol. Pharmacol. 8, 65-74.
7. Ennis, H. L. (1981) Antimicrob. Agents Chemother. 19, 657-665.
8. Waring, M. J. (1970) J. Mol. Biol. 54, 247-279.
9. Kersten, W., Kersten, H. & Szybalski, W. (1966) Biochemistry 5, 236-244.
10. Das, G. C., Dasgupta, S. & Das Gupta, N. N. (1974) Biochim. Biophys. Acta 353, 274-282.
11. Sinha, R. K., Talapatra, P., Mitra, A. & Mazumder, S. (1977) Biochim. Biophys. Acta 474, 199-209.
12. Plumbridge, T. W. & Brown, J. R. (1979) Biochem. Pharmacol. 28, 3231-3234.
13. Gale, E. F., Cundliffe, E., Reynolds, P. E., Richmond, M. H. & Waring, M. J. (1981) in The Molecular Basis of Antibiotic Action (Wiley, London), 2nd Ed., pp. 258-401.
14. Searle, M. S., Hall, J. G., Denny, W. A. & Wakelin, L. P. G. (1988) Biochemistry 27, 4340-4349.
15. Fox, K. R. & Waring, M. J. (1984) Biochim. Biophys. Acta 802, 162-168.
16. Fox, K. R., Brassett, C. & Waring, M. J. (1985) Biochim. Biophys. Acta 840, 383-392.
17. Collier, D. A., Neidle, S. & Brown, J. R. (1984) Biochem. Pharmacol. 33, 2877-2880.
18. Arora, S. K. (1983) J. Am. Chem. Soc. 105, 1328-1332.
19. Quigley, G. J., Wang, A. H.-J., Ughetto, G., van der Marel, G., van Boom, J. H. & Rich, A. (1980) Proc. Natl. Acad. Sci. USA 77, 7204-7208.
20. van der Marel, G. A., van Boeckel, C. A. A., Willie, G. & van Boom, J. H. (1981) Tetrahedron Lett. 22, 3887-3890.
21. Jones, T. A. (1978) J. Appl. Crystallogr. 11, 268-272.
22. Hendrickson, W. A. & Konnert, J. H. (1981) in Biomolecular Structure, Conformation, Function and Evolution, ed. Srinivasan, R. (Pergamon, Oxford), pp. 43-57.
23. Brünger, A., Kuriyan, J. & Karplus, M (1987) Science 235, 458-460.
24. Williams, L. D., Egli, M., Ughetto, G., van der Marel, G. A., van Boom, J. H., Rich, A., Wang, A. H.-J. & Frederick, C. A., J. Mol. Biol., in press.
25. Fox, K. R. (1988) Anti-Cancer Drug Design 3, 157-168.
26. Wang, A. H.-J., Ughetto, G., Quigley, G. J. & Rich, A. (1987) Biochemistry 26, 1152-1163.
27. Dickerson, R. E. et al. (1989) Nucleic Acids Res. 17, 1797-1803.
28. Moore, M. H., Hunter, W. N., Langlois d'Estaintot, B. & Kennard, O. (1989) J. Mol. Biol. 206, 693-705.
29. Frederick, C. A., Williams, L. D., Ughetto, G., van der Marel, G. A., van Boom, J. H., Rich, A. & Wang, A. H.-J., Biochemistry, in press.
30. Cruse, W. B. T., Salisbury, S. A., Brown, T., Cosstick, R., Eckstein, F. & Kennard, O. (1986)J. Mol. Biol. 192, 891-905.